BACKGROUND AND PURPOSE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an arteriopathic syndrome related to a genetic defect on chromosome 19. Characteristic changes in CADASIL can be observed onT2-weighted MR images in the subcortical white matter. The purpose of this study was to measure changes of regional cerebral blood volume (rCBV) with dynamic contrast-enhanced MR imaging and to correlate the changes to disability and cognitive performance. METHODS: We obtained rCBV measurements of 24 individuals with proven CADASIL on a 1.5-T MR imaging unit. A susceptibility-weighted MR imaging sequence was used for bolus tracking. Principles of the indicator dilution theory were applied to estimate values of absolute rCBV (mL/100 g). Disability was determined by using the Rankin scale, and overall cognitive performance was assessed by using the Mini-Mental State Examination. RESULTS: The mean rCBV in the subcortical white matter that was hyperintense on the T2-weighted images (2.7 +/- 0.8 mL/100 g) was significantly lower than the rCBV in the white matter that appeared normal on the T2-weighted images (4.4 +/- 1.3 mL/100 g) (P <.05). The mean rCBV in the gray matter was within the normal range (8.3 +/- 1.7 mL/100 g). Both cognitive impairment and disability negatively correlated with rCBV in the subcortical white matter that was hyperintense (P <.05) but not with rCBV in the normal appearing white matter. rCBV did not correlate with age. CONCLUSION: rCBV measured in the hyperintense subcortical white matter in individuals with CADASIL was decreased and inversely correlated with disability and cognitive impairment.
BACKGROUND AND PURPOSE:Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an arteriopathic syndrome related to a genetic defect on chromosome 19. Characteristic changes in CADASIL can be observed onT2-weighted MR images in the subcortical white matter. The purpose of this study was to measure changes of regional cerebral blood volume (rCBV) with dynamic contrast-enhanced MR imaging and to correlate the changes to disability and cognitive performance. METHODS: We obtained rCBV measurements of 24 individuals with proven CADASIL on a 1.5-T MR imaging unit. A susceptibility-weighted MR imaging sequence was used for bolus tracking. Principles of the indicator dilution theory were applied to estimate values of absolute rCBV (mL/100 g). Disability was determined by using the Rankin scale, and overall cognitive performance was assessed by using the Mini-Mental State Examination. RESULTS: The mean rCBV in the subcortical white matter that was hyperintense on the T2-weighted images (2.7 +/- 0.8 mL/100 g) was significantly lower than the rCBV in the white matter that appeared normal on the T2-weighted images (4.4 +/- 1.3 mL/100 g) (P <.05). The mean rCBV in the gray matter was within the normal range (8.3 +/- 1.7 mL/100 g). Both cognitive impairment and disability negatively correlated with rCBV in the subcortical white matter that was hyperintense (P <.05) but not with rCBV in the normal appearing white matter. rCBV did not correlate with age. CONCLUSION:rCBV measured in the hyperintense subcortical white matter in individuals with CADASIL was decreased and inversely correlated with disability and cognitive impairment.
Authors: B R Rosen; J W Belliveau; B R Buchbinder; R C McKinstry; L M Porkka; D N Kennedy; M S Neuder; C R Fisel; H J Aronen; K K Kwong Journal: Magn Reson Med Date: 1991-06 Impact factor: 4.668
Authors: H Chabriat; R Mrissa; C Levy; K Vahedi; H Taillia; M T Iba-Zizen; A Joutel; E Tournier-Lasserve; M G Bousser Journal: Stroke Date: 1999-02 Impact factor: 7.914
Authors: A Joutel; K Vahedi; C Corpechot; A Troesch; H Chabriat; C Vayssière; C Cruaud; J Maciazek; J Weissenbach; M G Bousser; J F Bach; E Tournier-Lasserve Journal: Lancet Date: 1997-11-22 Impact factor: 79.321
Authors: H Chabriat; C Levy; H Taillia; M T Iba-Zizen; K Vahedi; A Joutel; E Tournier-Lasserve; M G Bousser Journal: Neurology Date: 1998-08 Impact factor: 9.910
Authors: E Tournier-Lasserve; A Joutel; J Melki; J Weissenbach; G M Lathrop; H Chabriat; J L Mas; E A Cabanis; M Baudrimont; J Maciazek Journal: Nat Genet Date: 1993-03 Impact factor: 38.330
Authors: M Dichgans; M Mayer; I Uttner; R Brüning; J Müller-Höcker; G Rungger; M Ebke; T Klockgether; T Gasser Journal: Ann Neurol Date: 1998-11 Impact factor: 10.422
Authors: H Chabriat; K Vahedi; M T Iba-Zizen; A Joutel; A Nibbio; T G Nagy; M O Krebs; J Julien; B Dubois; X Ducrocq Journal: Lancet Date: 1995-10-07 Impact factor: 79.321
Authors: H H Jung; C Bassetti; E Tournier-Lasserve; K Vahedi; M Arnaboldi; V B Arifi; J M Burgunder Journal: J Neurol Neurosurg Psychiatry Date: 1995-08 Impact factor: 10.154
Authors: Yumi Yamamoto; Masafumi Ihara; Carina Tham; Roger W C Low; Janet Y Slade; Tim Moss; Arthur E Oakley; Tuomo Polvikoski; Raj N Kalaria Journal: Stroke Date: 2009-04-09 Impact factor: 7.914